AU2289495A - Dihydropyrimidine dehydrogenase compositions and methods of use - Google Patents
Dihydropyrimidine dehydrogenase compositions and methods of useInfo
- Publication number
- AU2289495A AU2289495A AU22894/95A AU2289495A AU2289495A AU 2289495 A AU2289495 A AU 2289495A AU 22894/95 A AU22894/95 A AU 22894/95A AU 2289495 A AU2289495 A AU 2289495A AU 2289495 A AU2289495 A AU 2289495A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- dihydropyrimidine dehydrogenase
- compositions
- dehydrogenase compositions
- dihydropyrimidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
- C12Y102/01002—Formate dehydrogenase (1.2.1.2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22735794A | 1994-04-13 | 1994-04-13 | |
US227357 | 1994-04-13 | ||
PCT/US1995/004567 WO1995028489A1 (en) | 1994-04-13 | 1995-04-13 | Dihydropyrimidine dehydrogenase compositions and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2289495A true AU2289495A (en) | 1995-11-10 |
Family
ID=22852774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU22894/95A Abandoned AU2289495A (en) | 1994-04-13 | 1995-04-13 | Dihydropyrimidine dehydrogenase compositions and methods of use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2289495A (en) |
WO (1) | WO1995028489A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856454A (en) * | 1994-09-12 | 1999-01-05 | The United States Of America As Represented By The Department Of Health And Human Services | CDNA for human and pig dihydropyrimidine dehydrogenase |
US6787306B1 (en) | 1996-03-20 | 2004-09-07 | The United States Of America As Represented By The Department Of Health And Human Services | Methods and compositions for detecting dihydropyrimidine dehydrogenase splicing mutations |
DE19837391A1 (en) * | 1997-08-22 | 1999-02-25 | Hoffmann La Roche | Monoclonal antibody specific for dihydropyrimidine dehydrogenase |
EP1232284A1 (en) * | 1999-11-15 | 2002-08-21 | University Of Southern California | Genomic polymorphism for predicting therapeutic response |
US20020142328A1 (en) | 2000-12-01 | 2002-10-03 | Danenberg Kathleen D. | Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors |
US7049059B2 (en) | 2000-12-01 | 2006-05-23 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
US6602670B2 (en) | 2000-12-01 | 2003-08-05 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on ERCC1 expression |
US7005278B2 (en) | 2001-03-02 | 2006-02-28 | Danenberg Kathleen D | Method of determining dihydropyrimidine dehydrogenase gene expression |
US6956111B2 (en) | 2001-03-02 | 2005-10-18 | Response Genetics, Inc. | Method of determining dihydropyrimidine dehydrogenase gene expression |
US6686155B2 (en) | 2001-06-14 | 2004-02-03 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
-
1995
- 1995-04-13 WO PCT/US1995/004567 patent/WO1995028489A1/en active Application Filing
- 1995-04-13 AU AU22894/95A patent/AU2289495A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1995028489A1 (en) | 1995-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6079598A (en) | Additive preparation and method of use thereof | |
AU2757097A (en) | Method of coating and compositions for use therein | |
AU4244596A (en) | Fluorocarbon containing coatings, compositions and methods of use | |
AU3850395A (en) | Hemorrhoidal compositions and method of use | |
AU5132296A (en) | Protective coating compositions and methods of use thereof | |
AU1532297A (en) | Starch-emulsifier composition and methods of making | |
AU4967296A (en) | Water stop compositions and methods of preparing same | |
AU4266596A (en) | Composition and use | |
AU2972597A (en) | Compositions and uses thereof | |
AU5800399A (en) | Polish composition and method of use | |
AU4083997A (en) | Gata-6 transcription factor: compositions and methods | |
AU2289495A (en) | Dihydropyrimidine dehydrogenase compositions and methods of use | |
AU3118297A (en) | Sok-1 and methods of use | |
AU1841195A (en) | 1-beta -methyl-carbapenem, compositions containing same and methods of use | |
AU6726498A (en) | Azeotropic or pseudoazeotropic compositions and use of these compositions | |
AU3730497A (en) | Compositions and articles of manufacture | |
AU6412599A (en) | Oxybutynin formulations and methods of use | |
AU1522400A (en) | Substituted pyrimidine compositions and methods of use | |
AU3630695A (en) | Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use | |
AU2962400A (en) | Cleaner composition and method of use thereof | |
AU4276496A (en) | 3-Thioheteroaryl cephalosporin compounds, compositions and methods of use | |
AU5456898A (en) | Compositions and articles of manufacture | |
AU1856297A (en) | Lyst1 and lyst2 gene compositions and methods of use | |
AU1299095A (en) | Antiinfective compositions and methods of use | |
AU2556195A (en) | CD40 binding compositions and methods of using same |